kentucky semaglutide gi obstruction legal team Who Should Not Take Ozempic? Contraindications For When GLP-1 Medications Aren't a Good Fit kentucky semaglutide gastroparesis legal team

Description

Off-Label Use: Some medications are prescribed off-label for weight loss: Semaglutide (Ozempic): FDA-approved for type 2 diabetes (not weight loss) Identical to Wegovy but different indication Commonly prescribed off-label for weight loss Same effectiveness as Wegovy Tirzepatide (Mounjaro): FDA-approved for type 2 diabetes (not weight loss) Identical to Zepbound but different indication Prescribed off-label for weight loss before Zepbound approval Same effectiveness as Zepbound Metformin: Diabetes medication sometimes used for weight loss Produces only 1-3% weight loss Not FDA-approved for weight loss Generally not recommended as primary weight loss medication The Current State of Weight Loss Medication: Clear Winners: GLP-1 receptor agonists (especially tirzepatide and semaglutide) have become the gold standard for medical weight loss, producing results previously unattainable with medication alone

The GLP1R rs6923761 variant and GIPR rs1800437 variant are key genetic markers associated with differences in glucose regulation and weight response

Published Phase 2 clinical data, reported in the New England Journal of Medicine, demonstrated substantial reductions in body weight over a 48-week treatment period across multiple dosing cohorts